Outset Medical, Inc. (OM)
NASDAQ: OM · Real-Time Price · USD
16.29
+0.99 (6.47%)
At close: May 12, 2025, 4:00 PM
16.64
+0.35 (2.15%)
After-hours: May 12, 2025, 6:55 PM EDT
Outset Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 115.27 | 113.69 | 130.38 | 115.38 | 102.6 | 49.94 | Upgrade
|
| Revenue Growth (YoY) | -7.84% | -12.80% | 13.00% | 12.45% | 105.47% | 231.18% | Upgrade
|
| Cost of Revenue | 73.28 | 74.55 | 101.25 | 97.54 | 94.99 | 62.97 | Upgrade
|
| Gross Profit | 41.99 | 39.14 | 29.13 | 17.83 | 7.61 | -13.04 | Upgrade
|
| Selling, General & Admin | 100.13 | 110.67 | 139.8 | 130 | 101.39 | 75.58 | Upgrade
|
| Research & Development | 29.17 | 36.29 | 56.57 | 48.86 | 36.74 | 28.85 | Upgrade
|
| Operating Expenses | 129.3 | 146.96 | 196.37 | 178.85 | 138.13 | 104.43 | Upgrade
|
| Operating Income | -87.31 | -107.82 | -167.24 | -161.02 | -130.52 | -117.47 | Upgrade
|
| Interest Expense | -21.46 | -23.87 | -12.68 | -3.57 | -1.72 | -2.89 | Upgrade
|
| Interest & Investment Income | 8.64 | 9.76 | 10.17 | 3.29 | 0.5 | 0.53 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | - | - | -0.09 | Upgrade
|
| EBT Excluding Unusual Items | -100.13 | -121.93 | -169.74 | -161.29 | -131.74 | -119.93 | Upgrade
|
| Merger & Restructuring Charges | -5.56 | -5.56 | -2.53 | - | - | - | Upgrade
|
| Other Unusual Items | -7.69 | - | - | -1.37 | - | -1.57 | Upgrade
|
| Pretax Income | -113.37 | -127.49 | -172.27 | -162.66 | -131.74 | -121.49 | Upgrade
|
| Income Tax Expense | 0.44 | 0.49 | 0.52 | 0.3 | 0.2 | - | Upgrade
|
| Earnings From Continuing Operations | - | -127.98 | -172.8 | -162.96 | -131.94 | -121.49 | Upgrade
|
| Net Income | -113.82 | -127.98 | -172.8 | -162.96 | -131.94 | -121.49 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | - | - | -42.17 | Upgrade
|
| Net Income to Common | -113.82 | -127.98 | -172.8 | -162.96 | -131.94 | -79.32 | Upgrade
|
| Shares Outstanding (Basic) | 4 | 3 | 3 | 3 | 3 | 1 | Upgrade
|
| Shares Outstanding (Diluted) | 4 | 3 | 3 | 3 | 3 | 1 | Upgrade
|
| Shares Change (YoY) | 30.93% | 4.76% | 2.96% | 5.64% | 178.69% | 1806.53% | Upgrade
|
| EPS (Basic) | -26.02 | -36.95 | -52.27 | -50.75 | -43.41 | -72.74 | Upgrade
|
| EPS (Diluted) | -26.02 | -36.95 | -52.27 | -50.75 | -43.41 | -72.74 | Upgrade
|
| Free Cash Flow | -96.97 | -117.22 | -134.81 | -154.05 | -133.37 | -108.09 | Upgrade
|
| Free Cash Flow Per Share | -22.16 | -33.84 | -40.78 | -47.98 | -43.88 | -99.12 | Upgrade
|
| Gross Margin | 36.43% | 34.43% | 22.34% | 15.46% | 7.41% | -26.11% | Upgrade
|
| Operating Margin | -75.74% | -94.84% | -128.27% | -139.56% | -127.21% | -235.24% | Upgrade
|
| Profit Margin | -98.73% | -112.57% | -132.54% | -141.24% | -128.59% | -158.85% | Upgrade
|
| Free Cash Flow Margin | -84.12% | -103.10% | -103.40% | -133.53% | -129.99% | -216.47% | Upgrade
|
| EBITDA | -81.61 | -102.09 | -161.43 | -155.85 | -125.36 | -114.31 | Upgrade
|
| EBITDA Margin | -70.79% | -89.80% | -123.82% | -135.08% | -122.18% | -228.91% | Upgrade
|
| D&A For EBITDA | 5.7 | 5.73 | 5.81 | 5.17 | 5.16 | 3.16 | Upgrade
|
| EBIT | -87.31 | -107.82 | -167.24 | -161.02 | -130.52 | -117.47 | Upgrade
|
| EBIT Margin | -75.74% | -94.84% | -128.27% | -139.56% | -127.21% | -235.24% | Upgrade
|
| Revenue as Reported | 115.27 | 113.69 | 130.38 | 115.38 | 102.6 | 49.94 | Upgrade
|
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.